KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to 0.51.

  • Bristol Myers Squibb's Debt Ratio fell 482.64% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year decrease of 482.64%. This contributed to the annual value of 0.54 for FY2024, which is 2827.97% up from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Debt Ratio is 0.51, which was down 482.64% from 0.52 recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Debt Ratio peaked at 0.56 during Q1 2024, and registered a low of 0.4 during Q3 2022.
  • For the 5-year period, Bristol Myers Squibb's Debt Ratio averaged around 0.46, with its median value being 0.42 (2023).
  • In the last 5 years, Bristol Myers Squibb's Debt Ratio crashed by 807.14% in 2023 and then soared by 4011.75% in 2024.
  • Bristol Myers Squibb's Debt Ratio (Quarter) stood at 0.41 in 2021, then dropped by 0.36% to 0.41 in 2022, then rose by 2.92% to 0.42 in 2023, then rose by 28.28% to 0.54 in 2024, then fell by 5.72% to 0.51 in 2025.
  • Its last three reported values are 0.51 in Q3 2025, 0.52 for Q2 2025, and 0.54 during Q1 2025.